• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏再同步治疗中经静脉左心室导线植入失败的处理策略:放弃还是抗争?

Strategy for Failed Transvenous Left-Ventricular Lead Placement in Cardiac Resynchronization Therapy: Surrender or Struggle?

机构信息

Division of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

Division of Cardiac Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

出版信息

Cardiology. 2022;147(1):47-56. doi: 10.1159/000519904. Epub 2021 Nov 29.

DOI:10.1159/000519904
PMID:34844237
Abstract

INTRODUCTION

For those cardiac resynchronization therapy (CRT) candidates who experience left-ventricular (LV) lead placement failure or underwent concomitant cardiac surgeries, surgical placement of epicardial LV lead guided by electroanatomic mapping may be a promising alternative.

METHODS

Electroanatomic mapping was used to guide positioning of the LV lead through a surgical approach. The LV lead was placed at the region with the latest local LV activation and normal voltage, away from the scar.

RESULTS

From April 2010 to September 2018, 10 consecutive patients (3 female) underwent surgical epicardial LV lead implantation. Among them, 3 had other surgical indications simultaneously (including 1 CRT non-responder), and 7 had failed transvenous LV lead placement. After CRT, the QRS duration was shortened from 149.3 ± 20.4 ms to 125.1 ± 15.2 ms (p = 0.01). At 6 months, the LV ejection fraction was significantly improved and remained stable in the follow-up (FU) period thereafter (baseline vs. 6 months, 31.0 ± 8.3% vs. 42.2 ± 13.4%, p = 0.006). Other parameters, including the threshold and impedance of the LV lead, were also stable at a mean FU of 755 ± 406 days, and the NYHA functional classification decreased from 2.9 ± 0.7 to 1.8 ± 0.8 (p = 0.002).

CONCLUSIONS

Placement of an epicardial LV lead guided by electroanatomic mapping could be used as an adjunctive strategy in patients who were unable or refractory to conventional CRT therapy. This approach could also be applied in patients who had other surgical indications at the same time.

摘要

简介

对于那些经历左心室(LV)导联放置失败或同时进行心脏手术的心脏再同步治疗(CRT)候选者,通过电解剖映射引导心外膜 LV 导联的手术放置可能是一种很有前途的替代方法。

方法

使用电解剖映射引导 LV 导联通过手术途径定位。LV 导联放置在局部 LV 激活最晚且电压正常的区域,远离疤痕。

结果

从 2010 年 4 月至 2018 年 9 月,连续 10 例患者(3 例女性)接受了手术心外膜 LV 导联植入。其中,3 例同时有其他手术指征(包括 1 例 CRT 无反应者),7 例经静脉 LV 导联放置失败。在 CRT 后,QRS 时限从 149.3 ± 20.4 ms 缩短至 125.1 ± 15.2 ms(p = 0.01)。在 6 个月时,LV 射血分数显著改善,随后随访期间保持稳定(基线 vs. 6 个月,31.0 ± 8.3% vs. 42.2 ± 13.4%,p = 0.006)。其他参数,包括 LV 导联的阈值和阻抗,在平均随访 755 ± 406 天后也保持稳定,NYHA 功能分类从 2.9 ± 0.7 降至 1.8 ± 0.8(p = 0.002)。

结论

电解剖映射引导的心外膜 LV 导联的放置可以作为对常规 CRT 治疗无反应或不耐受的患者的辅助策略。该方法也可以应用于同时有其他手术指征的患者。

相似文献

1
Strategy for Failed Transvenous Left-Ventricular Lead Placement in Cardiac Resynchronization Therapy: Surrender or Struggle?心脏再同步治疗中经静脉左心室导线植入失败的处理策略:放弃还是抗争?
Cardiology. 2022;147(1):47-56. doi: 10.1159/000519904. Epub 2021 Nov 29.
2
Left Ventricular Lead Placement Targeted at the Latest Activated Site Guided by Electrophysiological Mapping in Coronary Sinus Branches Improves Response to Cardiac Resynchronization Therapy.在冠状窦分支中通过电生理标测将左心室导线放置在最晚激活部位可改善心脏再同步治疗的反应。
J Cardiovasc Electrophysiol. 2015 Dec;26(12):1333-9. doi: 10.1111/jce.12771. Epub 2015 Sep 16.
3
Right ventricular septal pacing as alternative for failed left ventricular lead implantation in cardiac resynchronization therapy candidates.右室间隔部起搏作为心脏再同步治疗候选者中左心室起搏导线植入失败的替代方法。
Europace. 2015 Jan;17(1):94-100. doi: 10.1093/europace/euu259. Epub 2014 Oct 30.
4
Left ventricular lead placement in the latest activated region guided by coronary venous electroanatomic mapping.左心室导线放置于冠状静脉电解剖标测的最新激活区域。
Europace. 2015 Jan;17(1):84-93. doi: 10.1093/europace/euu221. Epub 2014 Sep 3.
5
Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial.靶向左心室导线放置指导心脏再同步治疗:TARGET 研究:一项随机对照试验。
J Am Coll Cardiol. 2012 Apr 24;59(17):1509-18. doi: 10.1016/j.jacc.2011.12.030. Epub 2012 Mar 7.
6
A novel approach for left ventricular lead placement in cardiac resynchronization therapy: Intraprocedural integration of coronary venous electroanatomic mapping with delayed enhancement cardiac magnetic resonance imaging.心脏再同步治疗中左心室导线置入的一种新方法:冠状动脉静脉电解剖标测与延迟强化心脏磁共振成像的术中整合。
Heart Rhythm. 2017 Jan;14(1):110-119. doi: 10.1016/j.hrthm.2016.09.015. Epub 2016 Sep 20.
7
Effects of epicardial versus transvenous left ventricular lead placement on left ventricular function and cardiac perfusion in cardiac resynchronization therapy: A randomized clinical trial.心脏再同步治疗中的心外膜与经静脉左心室导线置入对左心室功能和心脏灌注的影响:一项随机临床试验。
J Cardiovasc Electrophysiol. 2017 Aug;28(8):917-923. doi: 10.1111/jce.13242. Epub 2017 Jun 14.
8
Prognostic benefit of optimum left ventricular lead position in cardiac resynchronization therapy: follow-up of the TARGET Study Cohort (Targeted Left Ventricular Lead Placement to guide Cardiac Resynchronization Therapy).心脏再同步治疗中最佳左心室导线位置的预后获益:TARGET 研究队列的随访结果(靶向左心室导线位置指导心脏再同步治疗)。
JACC Heart Fail. 2014 Jun;2(3):205-12. doi: 10.1016/j.jchf.2013.11.010.
9
Coronary sinus activation patterns in patients with and without left bundle branch block undergoing electroanatomic mapping system-guided cardiac resynchronization therapy device implantation.在接受电解剖标测系统引导下心脏再同步治疗设备植入的有和无左束支传导阻滞患者中的冠状静脉窦激活模式
Heart Rhythm. 2017 Feb;14(2):225-233. doi: 10.1016/j.hrthm.2016.10.025. Epub 2016 Oct 28.
10
Does targeted positioning of the left ventricular pacing lead towards the latest local electrical activation in cardiac resynchronization therapy reduce the incidence of death or hospitalization for heart failure?心脏再同步治疗中,将左心室起搏导线靶向定位于最新的局部电激活位置是否能降低心力衰竭死亡或住院的发生率?
Am Heart J. 2023 Sep;263:112-122. doi: 10.1016/j.ahj.2023.05.011. Epub 2023 May 21.

引用本文的文献

1
Efficacy and safety of nicorandil for prevention of contrast-induced nephropathy in patients undergoing coronary procedures: a systematic review and meta-analysis.尼可地尔预防接受冠状动脉手术患者造影剂肾病的疗效和安全性:一项系统评价和荟萃分析。
Int Urol Nephrol. 2025 Feb 12. doi: 10.1007/s11255-025-04409-1.